Dr. Rainu Kaushal

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to improve care for the complex condition.

Researchers at Weill Cornell Medicine have used machine learning to define three subtypes of Parkinson’s disease based on the pace at which the disease progresses. 

While the peak of the COVID-19 pandemic seems to have passed, the effects of post-COVID conditions on public health remain. A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment. 

Black and Hispanic patients were more likely than white patients to develop a wide array of lasting symptoms and conditions after a COVID-19 diagnosis.

The post-COVID syndrome known as long COVID has four major subtypes defined by different clusters of symptoms.

A Weill Cornell Medicine-led database of more than 15 million patients has received close to $8 million in renewed funding from the Patient-Centered Outcomes Research Institute (PCORI) to expand the database and its use for health research for the next three years.

Three distinguished Weill Cornell Medicine physician-scientists, Dr. Joseph J. Fins, Dr. Rainu Kaushal and Dr. Shahin Rafii, have been elected to the esteemed Association of American Physicians (AAP).

Weill Cornell Medicine has been awarded a $9.8 million grant from the National Institutes of Health to lead a consortium of health care institutions that are analyzing nationwide health data in an effort to unravel the complexities of long COVID.

With more than $750 million raised already, the campaign creates a new synergy between Weill Cornell Medicine’s tri-partite mission to care, discover and teach, with a laser focus on three areas. 

Dr. Geraldine McGinty, an esteemed clinical operations strategist, administrator and radiologist, has been appointed senior associate dean for clinical affairs at Weill Cornell Medicine

Weill Cornell Medicine investigators have received a total of $3.5 million from the Patient-Centered Outcomes Research Institute (PCORI) to study the effectiveness of telehealth services during the COVID-19 pandemic, and to develop models that can aid in clinical decision making in the treatment of the virus.

Dr. Rainu Kaushal, a distinguished health services researcher, information scientist and healthcare leader, has been appointed senior associate dean for clinical research at Weill Cornell Medicine.

Weill Cornell Medicine and NewYork-Presbyterian have realigned the Department of Healthcare Policy and Research to address the intersection of research and practice. The newly named Department of Population Health Sciences, led by distinguished health services researcher, information scientist and leader Dr. Rainu Kaushal, aims to improve the health of populations through data-driven research, innovative technology and novel education programs.

With cases of COVID-19 spiking in many areas of the United States, and a greater resurgence expected in the fall, whether and how to reopen schools is the subject of strong national interest.

With the goal of advancing the fight against COVID-19, the Partners of Citadel and Citadel Securities have made a $2 million gift to Weill Cornell Medicine to develop new approaches to protect people from the disease and identify new cases of it.

Dr. Jyotishman Pathak is a researcher who jokingly says that he’s “still learning to fake business” after launching a new company just six months ago. Though new to the business world, by any measure, he’s already a success.

Dr. Rainu Kaushal, chair of the Department of Healthcare Policy and Research at Weill Cornell Medicine and physician-in-chief of healthcare policy and research at NewYork-Presbyterian/Weill Cornell Medical Center, and Dr. Deborah Estrin, a professor of healthcare policy and research at Weill Cornell Medicine and associate dean for impact at Cornell Tech, have been elected to the National Academy of Medicine (NAM).

Awards, honors, prizes and achievements for the month of August.

Dr. Lawrence Casalino, chief of the Division of Health Policy and Economics in the Department of Healthcare Policy and Research, and the Livingston Farrand Professor of Public Health at Weill Cornell Medicine, has been appointed to the Medicare Payment Advisory Commission (MedPAC) by the U.S. Government Accountability Office.

The Executive M.B.A./M.S. in Healthcare Leadership program, offered jointly by the Weill Cornell Graduate School of Medical Sciences and Cornell’s Samuel Curtis Johnson Graduate School of Management in May celebrated a milestone: graduating its first class of 39 students.